Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-16, Stock:NVS, The news for the past five days is as follows:
2019-01-09: NEWS1: Canopy Growth Moves to Key Resistance.NEWS2: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS3: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS4: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.
2019-01-10: NEWS1: European ADRs Move Higher in Thursday Trading.NEWS2: European ADRs Move Higher in Thursday Trading.NEWS3: Implied FVD Analyst Target Price: $34.NEWS4: Implied FVD Analyst Target Price: $34.NEWS5: Novartis migraine drug not cost effective - U.K. price watchdog.
2019-01-11: NEWS1: NASH Space in Focus in 2019 as Firms Look to Diversify.NEWS2: Will Tilray’s Dealmaking Lift Tilray Stock in 2019?.NEWS3: Will Tilray’s Dealmaking Lift Tilray Stock in 2019?.NEWS4: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS5: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS6: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS7: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS8: Will Tilray’s Dealmaking Lift Tilray Stock in 2019?.NEWS9: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS10: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.
2019-01-14: NEWS1: Tilray Shares Rally as Investor Plans Not to Sell Shares.NEWS2: Tilray Shares Rally as Investor Plans Not to Sell Shares.NEWS3: Tilray Shares Rally as Investor Plans Not to Sell Shares.
2019-01-15: NEWS1: Here's How The Government Shutdown Will Affect These Medical Stocks.

Answer: Rise